IE830187L - Nasal pharmaceutical compositions - Google Patents

Nasal pharmaceutical compositions

Info

Publication number
IE830187L
IE830187L IE830187A IE18783A IE830187L IE 830187 L IE830187 L IE 830187L IE 830187 A IE830187 A IE 830187A IE 18783 A IE18783 A IE 18783A IE 830187 L IE830187 L IE 830187L
Authority
IE
Ireland
Prior art keywords
pharmaceutical compositions
nasal pharmaceutical
esp
active material
ciliary function
Prior art date
Application number
IE830187A
Other versions
IE54532B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE830187L publication Critical patent/IE830187L/en
Publication of IE54532B1 publication Critical patent/IE54532B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceuticals for nasal administration contg. a pharmacologically active material (I), and opt. (I) or some other material, having the secondary effect of inducing an inhibition of ciliary function, and a non-toxic material (II) that is capable of stimulating ciliary function. Pref. the active material (I) is dehydroergotamine, esp. its mesylate, and the material (II) is a xanthine, esp. theophylline or caffeine. [FR2539994A1]
IE187/83A 1982-02-01 1983-01-31 Improvements in or relating to nasal pharmaceutical compositions IE54532B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
IE830187L true IE830187L (en) 1983-08-01
IE54532B1 IE54532B1 (en) 1989-11-08

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
IE187/83A IE54532B1 (en) 1982-02-01 1983-01-31 Improvements in or relating to nasal pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES519450A0 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (en) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド Intranasal delivery of dihydroergotamine by a precision olfactory device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
IL67822A (en) 1988-02-29
AU1085083A (en) 1983-08-11
MY8700766A (en) 1987-12-31
IT8347646A0 (en) 1983-02-01
NL192325B (en) 1997-02-03
IT1197558B (en) 1988-12-06
FR2539994B1 (en) 1986-10-10
ES8502865A1 (en) 1985-02-01
IL67822A0 (en) 1983-06-15
ES519450A0 (en) 1985-02-01
PT76166A (en) 1983-02-01
IT8347646A1 (en) 1984-08-01
GR81320B (en) 1984-12-11
SE8300495L (en) 1983-08-02
SE8300495D0 (en) 1983-01-31
IE54532B1 (en) 1989-11-08
NZ203117A (en) 1986-12-05
BE895750A (en) 1983-08-01
FI81258B (en) 1990-06-29
SG34389G (en) 1989-09-22
ATA30383A (en) 1987-10-15
NL192325C (en) 1997-06-04
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
FI81258C (en) 1990-10-10
DK164771B (en) 1992-08-17
JPH0253406B2 (en) 1990-11-16
NL8300325A (en) 1983-09-01
FR2539994A1 (en) 1984-08-03
HK59989A (en) 1989-08-04
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
HU191512B (en) 1987-02-27
FI830245A0 (en) 1983-01-25
DK38183A (en) 1983-08-02
CH653555A5 (en) 1986-01-15
SE454402B (en) 1988-05-02
DK164771C (en) 1992-12-28
AU565613B2 (en) 1987-09-24
AT385656B (en) 1988-05-10
PH22198A (en) 1988-06-28
JPS58134017A (en) 1983-08-10
FI830245L (en) 1983-08-02
DE3302949C2 (en) 1992-05-21
LU84613A1 (en) 1983-09-08
DE3302949A1 (en) 1983-08-11
DK38183D0 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
EP0296236A4 (en) Nasal delivery of caffeine.
IE870993L (en) Nasal administration compositions.
IE821214L (en) Medicament
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
IL78605A0 (en) Xanthine derivatives,their preparation and pharmaceutical compositions containing them
MY100998A (en) Pharmaceutical formulations
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PH25862A (en) IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
EP0396777A4 (en) Interferon preparation for nasal administration
EP0073819A4 (en) Nasal administration of beta-blockers and dosage forms therefor.
EP0161817A3 (en) Urogastrone
IE860785L (en) Composition for delivery of orally administered drugs
JPS5618982A (en) Pyrimidine derivatives and medicinal drug containing them
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
EP0284405A3 (en) Anti-viral compounds, dosage forms and methods
ZA855399B (en) Use of xanthine and thioxanthine derivatives for the preparation of medicaments
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
EP0476711A3 (en) Use of 5-fluorouracil for the treatment of AIDS
PT83305A (en) Process for the preparation of xanthine derivatives and pharmaceutical compositions containing them
DE3375783D1 (en) Phenyl-acetic-acid derivatives, their preparation and pharmaceutical compostions containing them
DK269986D0 (en) PROCEDURE FOR INCREASING THE TRANSDERMAL DELIVERY OF MEDICINAL PRODUCTS AND THE PREPARATION FOR TRANSDERMAL ADMINISTRATION
DE3368933D1 (en) Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
DE3164054D1 (en) Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts

Legal Events

Date Code Title Description
MK9A Patent expired